FNWFX
Price
$106.02
Change
-$1.96 (-1.82%)
Updated
Jul 2 closing price
Net Assets
90.88B
IJEMX
Price
$17.44
Change
-$0.41 (-2.30%)
Updated
Jul 2 closing price
Net Assets
210.01M
Interact to see
Advertisement

FNWFX vs IJEMX

FNWFX vs IJEMX Comparison Chart in %
View a ticker or compare two or three
VS
FNWFX vs. IJEMX commentary
Jul 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNWFX is a Buy and IJEMX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FNWFX has more cash in the bank: 90.9B vs. IJEMX (210M). FNWFX pays higher dividends than IJEMX: FNWFX (1.24) vs IJEMX (0.68). FNWFX was incepted earlier than IJEMX: FNWFX (9 years) vs IJEMX (21 years). IJEMX (1.26) is less costly to investors than FNWFX (0.57). FNWFX is a more actively managed with annual turnover of: 46.00 vs. IJEMX (37.00). IJEMX has a lower initial minimum investment than FNWFX: IJEMX (0) vs FNWFX (1000000). FNWFX annual gain was more profitable for investors over the last year : 20.57 vs. IJEMX (17.67). FNWFX return over 5 years is better than : 15.20 vs. IJEMX (-35.79).
FNWFXIJEMXFNWFX / IJEMX
Total Expense Ratio0.571.1948%
Annual Report Gross Expense Ratio0.571.2645%
Fund Existence9 years21 years-
Gain YTD13.71926.46852%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets90.9B210M43,286%
Annual Yield % from dividends1.240.68182%
Returns for 1 year20.5717.67116%
Returns for 3 years48.6341.33118%
Returns for 5 years15.20-35.79-42%
Returns for 10 yearsN/A25.64-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RAGHX29.890.83
+2.86%
Virtus KAR Health Sciences A
MINRX38.350.58
+1.54%
MFS International Intrinsic Equity R1
JORRX20.590.13
+0.64%
Janus Henderson Global Select R
TWAIX14.270.01
+0.07%
Thrivent International Equity S
IMIDX21.97-0.23
-1.04%
Congress Mid Cap Growth Institutional